electroCore (ECOR) Gross Profit (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.37% |
| Dec 31, 2025 | 9.37% |
| Sep 30, 2025 | 15.96% |
| Jun 30, 2025 | 12.90% |
| Mar 31, 2025 | -5.72% |
| Dec 31, 2024 | 10.26% |
| Sep 30, 2024 | 3.55% |
| Jun 30, 2024 | 16.38% |
| Mar 31, 2024 | 11.34% |
| Dec 31, 2023 | 6.34% |
| Sep 30, 2023 | 29.70% |
| Jun 30, 2023 | 27.73% |
| Mar 31, 2023 | 20.94% |
| Dec 31, 2022 | 11.76% |
| Sep 30, 2022 | -4.50% |
| Jun 30, 2022 | 16.89% |
| Mar 31, 2022 | 28.36% |
| Dec 31, 2021 | 5.92% |
| Sep 30, 2021 | 26.48% |
| Jun 30, 2021 | 6.55% |
| Mar 31, 2021 | 668.31% |
| Dec 31, 2020 | -85.09% |
| Sep 30, 2020 | 52.79% |
| Jun 30, 2020 | 10.17% |
| Mar 31, 2020 | 53.31% |
| Dec 31, 2019 | -13.64% |
| Sep 30, 2019 | -10.66% |
| Jun 30, 2019 | 46.26% |
| Mar 31, 2019 | 43.62% |
| Dec 31, 2018 | 225.25% |
| Sep 30, 2018 | -64.71% |
| Jun 30, 2018 | 373.77% |
| Mar 31, 2018 | 173.29% |
| Dec 31, 2017 | -128.39% |
| Sep 30, 2017 | 12.42% |